In Vivo Evidence of Complement Requirement for Mesangioproliferative Activity of Immune Complexes Containing Galactose-Deficient IgA1 in IgA Nephropathy

被引:0
|
作者
Moldoveanu, Zina [1 ]
Hall, Stacy D. [1 ]
Gurganus, Graham [1 ]
Novak, Lea [1 ]
Huang, Zhi Qiang [1 ]
Qiu Shihong [1 ]
Green, Todd J. [1 ]
Novak, Jan [1 ]
机构
[1] Univ Alabama Birmingham, Birmingham, AL USA
来源
关键词
D O I
10.1681/ASN.202426payzhp
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
FR-PO812
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy
    Wada, Yukihiro
    Matsumoto, Kei
    Suzuki, Taihei
    Saito, Tomohiro
    Kanazawa, Nobuhiro
    Tachibana, Shohei
    Iseri, Ken
    Sugiyama, Motonori
    Iyoda, Masayuki
    Shibata, Takanori
    PLOS ONE, 2018, 13 (11):
  • [32] CLINICAL SIGNIFICANCE OF SERUM AND MESANGIAL GALACTOSE-DEFICIENT IGA1 IN PATIENTS WITH IGA NEPHROPATHY
    Wada, Yukihiro
    Matsumoto, Kei
    Suzuki, Taihei
    Saito, Tomohiro
    Kanazawa, Nobuhiro
    Tachibana, Shohei
    Fukuda, Kei
    Iseri, Ken
    Iyoda, Masayuki
    Shibata, Takanori
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [33] Serum Galactose-Deficient IgA1 Level Is Not Associated with Proteinuria in Children with IgA Nephropathy
    Hastings, M. Colleen
    Afshan, Sabahat
    Sanders, John T.
    Kane, Oulimata
    Eison, T. Matthew
    Lau, Keith K.
    Moldoveanu, Zina
    Julian, Bruce A.
    Novak, Jan
    Wyatt, Robert J.
    INTERNATIONAL JOURNAL OF NEPHROLOGY, 2012, 2012
  • [34] Serum levels of galactose-deficient IgA1 in Chinese children with IgA nephropathy, IgA vasculitis with nephritis, and IgA vasculitis
    Mengmeng Tang
    Xue Zhang
    Xueqian Li
    Lei Lei
    Hejia Zhang
    Chen Ling
    Jie Ni
    Jicheng Lv
    Xiaorong Liu
    Xiangmei Chen
    Clinical and Experimental Nephrology, 2021, 25 : 37 - 43
  • [35] Serum levels of galactose-deficient IgA1 in Chinese children with IgA nephropathy, IgA vasculitis with nephritis, and IgA vasculitis
    Tang, Mengmeng
    Zhang, Xue
    Li, Xueqian
    Lei, Lei
    Zhang, Hejia
    Ling, Chen
    Ni, Jie
    Lv, Jicheng
    Liu, Xiaorong
    Chen, Xiangmei
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (01) : 37 - 43
  • [36] Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy
    Yamada, Koshi
    Huang, Zhi Qiang
    Raska, Milan
    Reily, Colin
    Anderson, Joshua C.
    Suzukia, Hitoshi
    Kiryluk, Krzysztof
    Gharavi, Ali G.
    Julian, Bruce A.
    Willey, Christopher D.
    Novak, Jan
    KIDNEY DISEASES, 2020, 6 (03) : 168 - 180
  • [37] Plasma Galactose-Deficient IgA1 and C3 and CKD Progression in IgA Nephropathy
    Chen, Pei
    Yu, Guizhen
    Zhang, Xue
    Xie, Xinfang
    Wang, Jinwei
    Shi, Sufang
    Liu, Lijun
    Lv, Jicheng
    Zhang, Hong
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (10): : 1458 - 1465
  • [38] Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy
    Kim, Min Jeong
    Schaub, Stefan
    Molyneux, Karen
    Koller, Michael T.
    Stampf, Susanne
    Barratt, Jonathan
    PLOS ONE, 2016, 11 (12):
  • [39] The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression
    Zhao, Na
    Hou, Ping
    Lv, Jicheng
    Moldoveanu, Zina
    Li, Yifu
    Kiryluk, Krzysztof
    Gharavi, Ali G.
    Novak, Jan
    Zhang, Hong
    KIDNEY INTERNATIONAL, 2012, 82 (07) : 790 - 796
  • [40] Plasma galactose-deficient IgA1 and C3 and CKD Progression in IgA nephropathy
    Yu, G. -Z.
    Chen, P.
    Zhang, X.
    Shi, S. -F.
    Lv, J. -C.
    Zhang, H.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 916 - 916